Cargando…
Applying proteomic technology to clinical virology
Developing antiviral drugs, vaccines and diagnostic markers is still the most ambitious challenge in clinical virology. In the past few decades, data from high‐throughput technologies have allowed for the rapid development of new antiviral therapeutic strategies, thus making a profound impact on tra...
Autores principales: | Mancone, C., Ciccosanti, F., Montaldo, C., Perdomo, A. B., Piacentini, M., Alonzi, T., Fimia, G. M., Tripodi, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129767/ https://www.ncbi.nlm.nih.gov/pubmed/23034105 http://dx.doi.org/10.1111/1469-0691.12029 |
Ejemplares similares
-
The microarray technology: facts and controversies
por: Lévêque, N., et al.
Publicado: (2012) -
Biological warfare, bioterrorism, and biocrime
por: Jansen, H. J., et al.
Publicado: (2014) -
Web‐based participatory surveillance of infectious diseases: the Influenzanet participatory surveillance experience
por: Paolotti, D., et al.
Publicado: (2013) -
Iron overload down-regulates the expression of the HIV-1 Rev cofactor eIF5A in infected T lymphocytes
por: Mancone, Carmine, et al.
Publicado: (2017) -
Endophthalmitis
por: Durand, M L
Publicado: (2013)